Satoshi Fukushima

9.4k total citations
309 papers, 6.1k citations indexed

About

Satoshi Fukushima is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Satoshi Fukushima has authored 309 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 79 papers in Molecular Biology and 57 papers in Pathology and Forensic Medicine. Recurrent topics in Satoshi Fukushima's work include Systemic Sclerosis and Related Diseases (39 papers), CAR-T cell therapy research (37 papers) and Immunotherapy and Immune Responses (28 papers). Satoshi Fukushima is often cited by papers focused on Systemic Sclerosis and Related Diseases (39 papers), CAR-T cell therapy research (37 papers) and Immunotherapy and Immune Responses (28 papers). Satoshi Fukushima collaborates with scholars based in Japan, United States and Spain. Satoshi Fukushima's co-authors include Hironobu Ihn, Masatoshi Jinnin, Ikko Kajihara, Takamitsu Makino, Shinichi Masuguchi, Katsunari Makino, Noritoshi Honda, Azusa Miyashita, Jun Aoi and Satoru Senju and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Chemical Physics.

In The Last Decade

Satoshi Fukushima

285 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Satoshi Fukushima Japan 40 2.2k 1.8k 1.5k 1.1k 1.1k 309 6.1k
Yoshitaka Okamoto Japan 50 1.9k 0.9× 1.3k 0.7× 1.9k 1.3× 1.4k 1.3× 238 0.2× 263 7.4k
Frédéric Blanchard France 44 2.7k 1.2× 2.4k 1.3× 1.4k 0.9× 662 0.6× 434 0.4× 146 6.1k
Christian F. Guerrero‐Juarez United States 22 2.8k 1.3× 1.1k 0.6× 1.9k 1.3× 743 0.7× 171 0.2× 32 6.2k
Yuichi Sato Japan 41 2.0k 0.9× 1.6k 0.9× 739 0.5× 519 0.5× 545 0.5× 363 6.6k
Yasuyuki Morishita Japan 47 4.0k 1.8× 2.6k 1.4× 1.9k 1.3× 1.1k 1.0× 455 0.4× 94 7.9k
Ulrich Rodeck United States 55 5.0k 2.3× 3.0k 1.7× 1.6k 1.1× 1.1k 1.0× 450 0.4× 166 8.9k
Jiří Bártek Denmark 41 2.2k 1.0× 2.0k 1.1× 405 0.3× 639 0.6× 471 0.4× 168 6.4k
Zhongchao Han China 63 5.8k 2.7× 1.8k 1.0× 1.7k 1.2× 1.9k 1.7× 640 0.6× 372 13.2k
Richard Grose United Kingdom 35 4.7k 2.2× 1.3k 0.7× 753 0.5× 1.1k 1.0× 238 0.2× 77 9.4k
Atsushi Shimizu Japan 44 1.7k 0.8× 1.5k 0.8× 329 0.2× 322 0.3× 498 0.5× 269 6.1k

Countries citing papers authored by Satoshi Fukushima

Since Specialization
Citations

This map shows the geographic impact of Satoshi Fukushima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Fukushima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Fukushima more than expected).

Fields of papers citing papers by Satoshi Fukushima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Fukushima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Fukushima. The network helps show where Satoshi Fukushima may publish in the future.

Co-authorship network of co-authors of Satoshi Fukushima

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Fukushima. A scholar is included among the top collaborators of Satoshi Fukushima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Fukushima. Satoshi Fukushima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jinnin, Masatoshi, Toshio Shimokawa, Akiko Kishi, et al.. (2025). Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial. The Journal of Dermatology. 52(5). 872–887. 1 indexed citations
2.
Sawamura, Soichiro, Ikko Kajihara, Katsunari Makino, et al.. (2024). Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata. BioScience Trends. 18(2). 198–200. 1 indexed citations
3.
Hayashi, Daiki, Hiromitsu Noguchi, Tadahiko Matsumoto, et al.. (2024). Onychomycosis caused by Aspergillus species belonging to section Circumdati. The Journal of Dermatology. 52(3). 536–540. 1 indexed citations
4.
5.
Kajihara, Ikko, R. Sakamoto, Soichiro Sawamura, et al.. (2023). <i>PIK3CA</i> mutations in cutaneous squamous cell carcinoma. Intractable & Rare Diseases Research. 12(3). 206–207. 3 indexed citations
6.
Noguchi, Hiromitsu, Tadahiko Matsumoto, Takashi Yaguchi, et al.. (2023). Onychomycosis Caused by Talaromyces muroii Successfully Treated with Efinaconazole. Mycopathologia. 188(5). 825–827. 2 indexed citations
7.
Noguchi, Hiromitsu, Tadahiko Matsumoto, Utako Kimura, et al.. (2022). Empiric antifungal therapy in patients with cutaneous and subcutaneous phaeohyphomycosis. The Journal of Dermatology. 49(5). 564–571. 4 indexed citations
8.
Kubo, Yosuke, Satoshi Fukushima, Hisashi Kanemaru, et al.. (2021). Immune cell therapy against disseminated melanoma by utilizing induced pluripotent stem cell-derived myeloid cell lines producing interferon-beta or interleukin-15/interleukin-15 receptor alpha. Journal of Dermatological Science. 102(2). 133–136. 1 indexed citations
9.
Noguchi, Hiromitsu, Tadahiko Matsumoto, Takashi Yaguchi, et al.. (2021). Subcutaneous cystic phaeohyphomycosis caused by Phaeoacremonium minimum. The Journal of Dermatology. 48(5). e234–e235.
10.
Kaneko, Akira, Hisashi Kanemaru, Ikko Kajihara, et al.. (2021). Liquid biopsy-based analysis by ddPCR and CAPP-Seq in melanoma patients. Journal of Dermatological Science. 102(3). 158–166. 9 indexed citations
11.
Nakamura, Yasuhiro, Jun Asai, Hiroshi Igaki, et al.. (2019). Japanese Dermatological Association Guidelines: Outlines of guidelines for cutaneous melanoma 2019. The Journal of Dermatology. 47(2). 89–103. 33 indexed citations
12.
Noguchi, Hiromitsu, et al.. (2018). Topical efinaconazole: A promising therapeutic medication for tinea unguium. The Journal of Dermatology. 45(10). 1225–1228. 6 indexed citations
13.
Tsukamoto, Hirotake, Koji Fujieda, Azusa Miyashita, et al.. (2018). Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment. Cancer Research. 78(17). 5011–5022. 234 indexed citations
14.
Takamatsu, Koutaro, Shunya Nakane, Shigeaki Suzuki, et al.. (2018). Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia. Annals of Clinical and Translational Neurology. 5(11). 1421–1427. 29 indexed citations
15.
Miyashita, Azusa, Satoshi Fukushima, Satoshi Nakahara, et al.. (2016). Immunotherapy against Metastatic Melanoma with Human iPS Cell–Derived Myeloid Cell Lines Producing Type I Interferons. Cancer Immunology Research. 4(3). 248–258. 24 indexed citations
16.
Jinnin, Masatoshi, Mikio Masuzawa, Zhongzhi Wang, et al.. (2015). NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma. Cancer Research. 75(21). 4458–4465. 41 indexed citations
17.
Aoi, Jun, Motoyoshi Endo, Tsuyoshi Kadomatsu, et al.. (2013). Angiopoietin-like Protein 2 Accelerates Carcinogenesis by Activating Chronic Inflammation and Oxidative Stress. Molecular Cancer Research. 12(2). 239–249. 52 indexed citations
18.
Masuguchi, Shinichi, Masatoshi Jinnin, Satoshi Fukushima, et al.. (2011). The expression of HER-2 in extramammary Paget&apos;s disease. BioScience Trends. 5(4). 151–155. 24 indexed citations
19.
Fukushima, Satoshi, et al.. (1991). Door impact test procedure and crush characteristics for side impact occupant protection. 1993. 609–615. 4 indexed citations
20.
Miyase, Toshio, et al.. (1981). マルバハギの成分 II ハギニン‐C,ハギニン‐Dおよびレスペデオール‐Cの構造. Chemical and Pharmaceutical Bulletin. 29(8). 2205–2209. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Okamoto Breakdown of academic impact, for papers by Frédéric Blanchard Breakdown of academic impact, for papers by Christian F. Guerrero‐Juarez Breakdown of academic impact, for papers by Yuichi Sato Breakdown of academic impact, for papers by Yasuyuki Morishita Breakdown of academic impact, for papers by Ulrich Rodeck Breakdown of academic impact, for papers by Jiří Bártek Breakdown of academic impact, for papers by Zhongchao Han Breakdown of academic impact, for papers by Richard Grose Breakdown of academic impact, for papers by Atsushi Shimizu
Rankless by CCL
2026